Everhart Financial Group »

Oncolytics Biotech shares owned by Everhart Financial Group

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Everhart Financial Group from 13F filings

Historical chart of Everhart Financial Group investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Everhart Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Everhart Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $117k 138k 0.85

More positions owned by Everhart Financial Group

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Apple (AAPL)
Vanguard Bd Index Fds Intermed Term (BIV)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Everhart Financial Group

Top funds holding Oncolytics Biotech

Sandbox Financial Partners
Marshall Wace
Seeds Investor
Tocqueville Asset Management
Everhart Financial Group
Doliver Capital Advisors
LPL Financial
XTX Topco
Virtu Financial
Franklin Resources
Geode Capital Management
CIBC World Markets
PFG Investments
UBS Group
Atlantic Trust

View all funds holding Oncolytics Biotech